HCW Biologics Inc. (HCWB)
1.18
-0.27
(-18.62%)
USD |
NASDAQ |
Jun 09, 16:00
1.18
0.00 (0.00%)
After-Hours: 17:25
HCW Biologics EPS Diluted (Quarterly) : 0.3657 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8121 |
| Longeveron, Inc. | -0.1911 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.984M |
| Revenue (Quarterly) | 6.543M |
| Total Expenses (Quarterly) | 4.559M |
| Enterprise Value | 15.11M |
| Gross Profit Margin (Quarterly) | 97.66% |
| Profit Margin (Quarterly) | 30.32% |
| Earnings Yield | -801.7% |
| Normalized Earnings Yield | -904.31 |